Connor, Clark & Lunn Investment Management (CC&L)
LLY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Eli Lilly LLY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236M Buy
256,933
+180,032
+234% +$183M 0.54% 34
2025
Q4 		$82.6M Buy
76,901
+27,831
+57% +$26.6M 0.22% 100
2025
Q3 		$37.4M Buy
49,070
+6,997
+17% +$5.21M 0.12% 165
2025
Q2 		$32.8M Buy
42,073
+8,055
+24% +$6.26M 0.12% 157
2025
Q1 		$28.1M Buy
34,018
+4,688
+16% +$3.9M 0.12% 139
2024
Q4 		$22.6M Sell
29,330
-28,714
-49% -$23.8M 0.1% 154
2024
Q3 		$51.4M Buy
58,044
+3,644
+7% +$3.28M 0.25% 64
2024
Q2 		$49.3M Buy
54,400
+4,819
+10% +$3.85M 0.21% 99
2024
Q1 		$38.6M Sell
49,581
-15,504
-24% -$11M 0.17% 118
2023
Q4 		$37.9M Sell
65,085
-45,630
-41% -$26.6M 0.18% 109
2023
Q3 		$59.5M Buy
110,715
+98,154
+781% +$50.6M 0.31% 66
2023
Q2 		$5.89M Sell
12,561
-26,685
-68% -$11.2M 0.03% 362
2023
Q1 		$13.5M Sell
39,246
-23,654
-38% -$7.98M 0.07% 208
2022
Q4 		$23M Sell
62,900
-10,391
-14% -$3.68M 0.13% 123
2022
Q3 		$23.7M Sell
73,291
-117,819
-62% -$37.3M 0.16% 105
2022
Q2 		$62M Sell
191,110
-15,954
-8% -$4.79M 0.38% 44
2022
Q1 		$59.3M Buy
207,064
+91,244
+79% +$23.5M 0.29% 61
2021
Q4 		$32M Sell
115,820
-41,328
-26% -$10.5M 0.16% 121
2021
Q3 		$36.3M Sell
157,148
-28,028
-15% -$6.92M 0.19% 103
2021
Q2 		$42.5M Sell
185,176
-54,254
-23% -$10.9M 0.22% 91
2021
Q1 		$44.7M Buy
239,430
+155,211
+184% +$30.4M 0.25% 86
2020
Q4 		$14.2M Sell
84,219
-99,018
-54% -$14.8M 0.08% 186
2020
Q3 		$27.1M Buy
183,237
+98,100
+115% +$15.2M 0.18% 112
2020
Q2 		$14M Buy
+85,137
New +$13.1M 0.1% 166
2020
Q1 		– Sell
-76,066
Closed -$10M – 1100
2019
Q4 		$10M Sell
76,066
-221,500
-74% -$25.7M 0.07% 185
2019
Q3 		$33.3M Sell
297,566
-75,159
-20% -$8.37M 0.23% 87
2019
Q2 		$41.3M Buy
372,725
+174,975
+88% +$20.6M 0.26% 70
2019
Q1 		$25.7M Buy
+197,750
New +$24M 0.17% 107
2018
Q2 		– Sell
-92,575
Closed -$7.16M – 1071
2018
Q1 		$7.16M Buy
92,575
+25,175
+37% +$2.03M 0.04% 240
2017
Q4 		$5.69M Sell
67,400
-11,950
-15% -$1.02M 0.03% 271
2017
Q3 		$6.79M Buy
+79,350
New +$6.51M 0.04% 256
2016
Q2 		– Sell
-47,925
Closed -$3.45M – 904
2016
Q1 		$3.45M Sell
47,925
-39,075
-45% -$2.96M 0.03% 267
2015
Q4 		$7.33M Buy
87,000
+27,275
+46% +$2.26M 0.06% 175
2015
Q3 		$5M Buy
+59,725
New +$5.04M 0.04% 201
2015
Q2 		– Sell
-41,100
Closed -$2.99M – 641
2015
Q1 		$2.99M Sell
41,100
-1,800
-4% -$128K 0.03% 197
2014
Q4 		$2.96M Sell
42,900
-15,700
-27% -$1.06M 0.02% 197
2014
Q3 		$3.8M Buy
58,600
+15,000
+34% +$950K 0.03% 162
2014
Q2 		$2.89M Buy
+43,600
New +$2.6M 0.02% 207
2014
Q1 		– Sell
-146,632
Closed -$7.95M – 730
2013
Q4 		$7.95M Buy
146,632
+46,002
+46% +$2.3M 0.06% 120
2013
Q3 		$5.21M Buy
100,630
+23,000
+30% +$1.2M 0.05% 106
2013
Q2 		$4.02M Buy
+77,630
New +$4.22M 0.04% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s LLY Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Eli Lilly (LLY) stake by 234% in Q1 2026, buying an estimated $183M and bringing the position to 256,933 shares worth $236M. The position accounts for 0.54% of the portfolio, ranked #34.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 256,933 shares of Eli Lilly worth $236M as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 180,032 Eli Lilly shares in Q1 2026, an estimated $183M.
  • Eli Lilly made up 0.54% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #34 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.